Mail

UK markets close in 5 hours 51 minutes

FTSE 100
8,111.26
+32.40(+0.40%)
FTSE 250
19,841.36
+239.38(+1.22%)
AIM
755.73
+2.61(+0.35%)
GBP/EUR
1.1658
+0.0002(+0.01%)
GBP/USD
1.2512
+0.0001(+0.01%)
Bitcoin GBP
51,565.22
+415.98(+0.81%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Sartorius Stedim Biotech S.A. (0RG8.IL)

IOB - IOB Delayed price. Currency in EUR

Add to watchlist

207.20

+5.70

(+2.83%)

As of 10:10AM BST. Market open.

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	19.79B
Enterprise value	23.36B
Trailing P/E	59.97
Forward P/E	33.90
PEG ratio (5-yr expected)	1.34
Price/sales (ttm)	6.69
Price/book (mrq)	7.43
Enterprise value/revenue	8.42
Enterprise value/EBITDA	30.91

Trading information

Stock price history

Beta (5Y monthly)	0.48
52-week change ³	-13.41%
S&P500 52-week change ³	21.08%
52-week high ³	287.60
52-week low ³	160.10
50-day moving average ³	253.16
200-day moving average ³	235.69

Share statistics

Avg vol (3-month) ³	102.84k
Avg vol (10-day) ³	118.71k
Shares outstanding ⁵	92.16M
Implied shares outstanding ⁶	114.27M
Float ⁸	24.21M
% held by insiders ¹	73.60%
% held by institutions ¹	13.95%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	1.44
Forward annual dividend yield ⁴	0.78%
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	20.87%
Dividend date ³	N/A
Ex-dividend date ⁴	30 Mar 2023
Last split factor ²	6:1
Last split date ³	06 May 2016

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Sept 2023

Profitability

Profit margin	15.56%
Operating margin (ttm)	23.22%

Management effectiveness

Return on assets (ttm)	6.58%
Return on equity (ttm)	18.66%

Income statement

Revenue (ttm)	2.96B
Revenue per share (ttm)	32.11
Quarterly revenue growth (yoy)	-24.10%
Gross profit (ttm)	1.83B
EBITDA	879.1M
Net income avi to common (ttm)	460.4M
Diluted EPS (ttm)	6.90
Quarterly earnings growth (yoy)	-87.40%

Balance sheet

Total cash (mrq)	118.7M
Total cash per share (mrq)	1.29
Total debt (mrq)	3.79B
Total debt/equity (mrq)	144.33%
Current ratio (mrq)	1.79
Book value per share (mrq)	28.27

Cash flow statement

Operating cash flow (ttm)	625.3M
Levered free cash flow (ttm)	-22.32M